Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection. [electronic resource]

By: Contributor(s): Producer: 20120504Description: e112-9 p. digitalISSN:
  • 1365-2893
Subject(s): Online resources: In: Journal of viral hepatitis vol. 19
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase I; Journal Article

There are no comments on this title.

to post a comment.